Author(s): Itzhaki I, Maizels L, Huber I, Zwi-Dantsis L, Caspi O, et al.
The ability to generate patient-specific human induced pluripotent stem cells (iPSCs) offers a new paradigm for modelling human disease and for individualizing drug testing. Congenital long QT syndrome (LQTS) is a familial arrhythmogenic syndrome characterized by abnormal ion channel function and sudden cardiac death. Here we report the development of a patient/disease-specific human iPSC line from a patient with type-2 LQTS (which is due to the A614V missense mutation in the KCNH2 gene). The generated iPSCs were coaxed to differentiate into the cardiac lineage. Detailed whole-cell patch-clamp and extracellular multielectrode recordings revealed significant prolongation of the action-potential duration in LQTS human iPSC-derived cardiomyocytes (the characteristic LQTS phenotype) when compared to healthy control cells. Voltage-clamp studies confirmed that this action-potential-duration prolongation stems from a significant reduction of the cardiac potassium current I(Kr). Importantly, LQTS-derived cells also showed marked arrhythmogenicity, characterized by early-after depolarizations and triggered arrhythmias. We then used the LQTS human iPSC-derived cardiac-tissue model to evaluate the potency of existing and novel pharmacological agents that may either aggravate (potassium-channel blockers) or ameliorate (calcium-channel blockers, K(ATP)-channel openers and late sodium-channel blockers) the disease phenotype. Our study illustrates the ability of human iPSC technology to model the abnormal functional phenotype of an inherited cardiac disorder and to identify potential new therapeutic agents. As such, it represents a promising paradigm to study disease mechanisms, optimize patient care (personalized medicine), and aid in the development of new therapies.
Referred From: https://pubmed.ncbi.nlm.nih.gov/21240260/
Author(s): Nishiyama A, Xin L, Sharov AA, Thomas M, Mowrers G, et al.
Author(s): Nichols J, Smith A
Author(s): Gangaraju VK, Lin H
Author(s): Yamanaka S, Blau HM
Author(s): Takahashi K, Yamanaka S
Author(s): Stadtfeld M, Maherali N, Breault DT, Hochedlinger K
Author(s): Chan EM, Ratanasirintrawoot S, Park IH, Manos PD, Loh YH, et al.
Author(s): Payer B, Lee JT, Namekawa SH
Author(s): Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, et al.
Author(s): Kim K, Doi A, Wen B, Ng K, Zhao R, et al.
Author(s): Hu Q, Friedrich AM, Johnson LV, Clegg DO
Author(s): BarNur O, Russ HA, Efrat S, Benvenisty N
Author(s): Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, et al.
Author(s): Marchetto MC, Carromeu C, Acab A, Yu D, Yeo GW, et al.
Author(s): Kim K, Zhao R, Doi A, Ng K, Unternaehrer J, et al.
Author(s): Zhao T, Zhang ZN, Rong Z, Xu Y
Author(s): Gurdon JB, Wilmut I
Author(s): Awe JP, Byrne JA
Author(s): Xu F, Flowers S, Moran E
Author(s): Houlard M, Berlivet S, Probst AV, Quivy JP, Héry P, et al.
Author(s): Pivot-Pajot C, Caron C, Govin J, Vion A, Rousseaux S, et al.
Author(s): Kim SK, Suh MR, Yoon HS, Lee JB, Oh SK, et al.
Author(s): Liu YJ, Nakamura T, Nakano T
Author(s): Jude CD, Climer L, Xu D, Artinger E, Fisher JK, et al.
Author(s): Shogren-Knaak M, Ishii H, Sun JM, Pazin MJ, Davie JR, et al.
Author(s): Becker M, Becker A, Miyara F, Han Z, KiharaM,et al.
Author(s): Aoto T, Saitoh N, Sakamoto Y, Watanabe S, Nakao M
Author(s): Lee G, Papapetrou EP, Kim H, Chambers SM, Tomishima MJ, et al.
Author(s): Moretti A, Bellin M, Welling A, Jung CB, Lam JT, et al.